Cited 0 times in
Reply to: "Can sorafenib use influence outcome when comparing stereotactic body radiation therapy with radiofrequency ablation in patients with hepatocellular carcinoma?"
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.